{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:43:26Z","timestamp":1790462606728,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.cmi.2020.04.026","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T02:37:23Z","timestamp":1587782243000},"page":"917-921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"title":["Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study"],"prefix":"10.1016","volume":"26","author":[{"given":"N.","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.04.026_bib1","first-page":"100124","article-title":"From SARS to COVID-19: a previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans \u2013 call for a One Health approach","volume":"9","author":"El Zowalaty","year":"2020","journal-title":"One Health (Amsterdam, Netherlands)"},{"key":"10.1016\/j.cmi.2020.04.026_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25766","article-title":"Coronavirus disease 2019: what we know?","author":"He","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cmi.2020.04.026_bib3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3389\/fmicb.2019.01327","article-title":"Overview of current therapeutics and novel candidates against influenza, respiratory syncytial virus, and Middle East Respiratory syndrome coronavirus infections","volume":"10","author":"Behzadi","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2020.04.026_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2020.04.026_bib5","article-title":"Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection","author":"Sun","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cmi.2020.04.026_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25071577","article-title":"Antioxidant potential of antiviral drug umifenovir","volume":"25","author":"Proskurnina","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cmi.2020.04.026_bib7","first-page":"9","article-title":"[Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures]","volume":"53","author":"Khamitov","year":"2008","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.cmi.2020.04.026_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","volume":"14","author":"Lu","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.cmi.2020.04.026_bib9","article-title":"Arbidol combined with LPV\/r versus LPV\/r alone against corona virus disease 2019: a retrospective cohort study","author":"Deng","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2020.04.026_bib10","series-title":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance","year":"2020"},{"key":"10.1016\/j.cmi.2020.04.026_bib11","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1148\/radiol.2363040958","article-title":"Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT","volume":"236","author":"Chang","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.cmi.2020.04.026_bib12","series-title":"Novel coronavirus pneumonia prevention and control program (7th ed.)","year":"2020"},{"key":"10.1016\/j.cmi.2020.04.026_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2217\/fvl.11.33","article-title":"Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy","volume":"6","author":"Barnard","year":"2011","journal-title":"Future Virol"},{"key":"10.1016\/j.cmi.2020.04.026_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov Ther"},{"issue":"2","key":"10.1016\/j.cmi.2020.04.026_bib15","first-page":"86","article-title":"Efficacy of lopinavir, ritonavir and arbidol for the treatment of new coronavirus pneumonia","volume":"38","author":"Chen","year":"2020","journal-title":"Chin J Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20302342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20302342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:27:17Z","timestamp":1761118037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X20302342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1198743X20302342"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.04.026","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}